Limitations of VEINES QOL/SYM for discriminating chronic venous insufficiency severity.
Giane Amorim Ribeiro-Samora, Maria Luiza Vieira Carvalho, Regina Márcia Faria de Moura...
https://pubmed.ncbi.nlm.nih.gov/31839797/Actively Recruiting
Led by University of Sao Paulo · Updated on 2026-10-05
70
Participants Needed
1
Research Sites
12 weeks
Total Duration
Researchers are evaluating two treatments for reticular veins and telangiectasias, which are common signs of chronic venous disease classified as CEAP C1. These vein issues, often seen as cosmetic concerns, can cause discomfort and impact quality of life and body image. The study compares isolated polidocanol foam sclerotherapy alone versus a combined Cryo-Laser After Foam CLaF technique that adds transdermal laser treatment to the foam sclerotherapy. This prospective, randomized, controlled clinical trial includes 70 women aged 18 to 60 with bilateral, symmetrical vein conditions.
CONDITIONS
Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias
C
Cecília S Ulacia, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Sao Paulo
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are evaluated to confirm they meet eligibility requirements for the trial.
1 visit (in-person)
Duration - Single treatment session
Each participant receives polidocanol foam sclerotherapy alone on one leg and the combined Cryo-Laser After Foam technique on the other leg, with treatment side assigned randomly.
1 visit (in-person)
Duration - 180 days
Participants attend follow-up visits to assess vein clearance, skin pigmentation, pain, adverse effects, and quality of life up to 180 days after treatment.
Multiple visits at days 21, 60, 90, and 180
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Giane Amorim Ribeiro-Samora, Maria Luiza Vieira Carvalho, Regina Márcia Faria de Moura...
https://pubmed.ncbi.nlm.nih.gov/31839797/Marcos M Fonseca, Faberson J Mocelin, Lara R Poltronieri...
https://pubmed.ncbi.nlm.nih.gov/39027725/L Tessari, A Cavezzi, A Frullini
https://pubmed.ncbi.nlm.nih.gov/11231246/Matheus Bertanha, Rodrigo Gibin Jaldin, Regina Moura...
https://pubmed.ncbi.nlm.nih.gov/28973414/Javier Moreno-Moraga, Mihail L Pascu, Justo M Alcolea...
https://pubmed.ncbi.nlm.nih.gov/30707327/Javier Moreno-Moraga, Adriana Smarandache, Mihail L Pascu...
https://pubmed.ncbi.nlm.nih.gov/23989971/Matheus Bertanha, Winston B Yoshida, Paula A Bueno de Camargo...
https://pubmed.ncbi.nlm.nih.gov/32778489/Luis Cu Nakano, Daniel G Cacione, Jose Cc Baptista-Silva...
https://pubmed.ncbi.nlm.nih.gov/34637138/Javier Moreno-Moraga, Esteban Hernández, Josefina Royo...
https://pubmed.ncbi.nlm.nih.gov/22886138/University of Sao Paulo
Lead Sponsor